Categories: Technology

CompoSecure Schedules Third Quarter 2025 Conference Call for November 10th at 5:00 p.m. ET

 | Source: CompoSecure, Inc.

SOMERSET, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) — CompoSecure, Inc. (NYSE: CMPO), a leader in metal payment cards, security, and authentication solutions, will host a conference call on Monday, November 10, 2025, at 5:00 p.m. Eastern Standard Time (EST) to discuss its financial results for the third quarter ended September 30, 2025. The Company’s results will be reported in a press release prior to the call.

CompoSecure’s leadership will host the conference call, followed by a question-and-answer period.

Date: Monday, November 10, 2025
Time: 5:00 p.m. EST
Dial-in registration link: here
Live webcast registration link: here

We encourage all participants to register at least 15 minutes prior to the 5:00 p.m. EST start time. A live webcast and replay will be available at https://ir.composecure.com/news-events/events. If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

About CompoSecure

Founded in 2000, CompoSecure (NYSE: CMPO) is a technology partner to market leaders, fintechs and consumers enabling trust for millions of people around the globe. The company combines elegance, simplicity and security to deliver exceptional experiences and peace of mind in the physical and digital world. CompoSecure’s innovative payment card technology and metal cards with Arculus security and authentication capabilities deliver unique, premium branded experiences, enable people to access and use their financial and digital assets, and ensure trust at the point of a transaction. For more information, please visit www.CompoSecure.com and www.GetArculus.com.

Corporate Contact

Anthony Piniella
Head of Communications, CompoSecure
(917) 208-7724
apiniella@composecure.com

Investor Relations Contact

Sean Mansouri, CFA
Elevate IR
(720) 330-2829
CMPO@elevate-ir.com

GlobeNews Wire

Recent Posts

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026 16:05 ET  | Source: Context Therapeutics Inc. PHILADELPHIA, Jan. 16, 2026 (GLOBE…

2 hours ago

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026 16:05 ET  | Source: CAMP4 Therapeutics CAMBRIDGE, Mass., Jan. 16, 2026 (GLOBE…

2 hours ago

Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Company to host conference call and webcast on Tuesday, January 20, 2026 at 8:00 am…

2 hours ago

NeuroDyne Drops: Sharp Mind, Enhanced Memory, and Lasting Focus As Nature Intended, Ingredients

NEURODYNE DROPS INTRODUCED AS A COGNITIVE WELLNESS SUPPLEMENT SUPPORTING HEALTHY MEMORY, FOCUS, AND MENTAL CLARITY…

11 hours ago

Optivell Officially Announced as a Vision Support Formula for Preventive Eye Wellness

New York City, NY, Jan. 17, 2026 (GLOBE NEWSWIRE) -- OPTIVELL INTRODUCED AS A NEW…

11 hours ago

Sugar Clean Drops: Top Blood Sugar Support Supplement for Metabolic Wellness and Energy Support

SUGAR CLEAN DROPS ANNOUNCED AS A NEW SUPPLEMENT SUPPORTING HEALTHY BLOOD SUGAR AND METABOLIC WELLNESS…

11 hours ago